Prices delayed by at least 15 minutes | Print
Ishares Iv PLC ISHARES NASDAQ US BIOTEC UCITS USD (ACC)
Open
$10.465
Previous close
$10.47
Trade high
$10.54
Income frequency
-
Year low
$7.91
Year high
$10.98
Replication method
Physical Full
Volume
66,242
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.35
ISIN
IE00BYXG2H39
Share price
Asset allocation
Top 10 holdings
| Holdings 12/11/2026 | % of assets |
|---|---|
| Gilead Sciences Inc | 9.02 |
| Amgen Inc | 8.51 |
| Vertex Pharmaceuticals Inc | 7.82 |
| Regeneron Pharmaceuticals Inc | 6.18 |
| Moderna Inc | 5.93 |
| Revolution Medicines Inc Ordinary Shares | 2.43 |
| Biogen Inc | 2.38 |
| Illumina Inc | 2.03 |
| Royalty Pharma PLC Class A | 1.97 |
| Roivant Sciences Ltd Ordinary Shares | 1.86 |
Investment objective
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.